AstraZeneca proposes a direct NYSE listing to broaden its global investor base and simplify access for U.S. investors, while Enhertu shows benefit in a clinical trial.
John Oliver criticizes Israeli PM Netanyahu's controversial leadership, alliance with extremists, and policies worsening the Gaza crisis amid Israel's longest war.
AstraZeneca proposes a direct NYSE listing to broaden its global investor base and simplify access for U.S. investors, while Enhertu shows benefit in a clinical trial.
John Oliver criticizes Israeli PM Netanyahu's controversial leadership, alliance with extremists, and policies worsening the Gaza crisis amid Israel's longest war.